Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Completed 3

Sponsor Class

NIH 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Medulloblastoma 2Central Nervous System Neoplasms 2Optic Nerve Glioma 1Glioma 1Familial ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × RMP 7 × Clear all
NCT00005602 2014-02-21

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Children's Oncology Group

Phase 1 Completed
13 enrolled
CNS

Central Nervous System Neoplasms

NCT00019422 2013-08-16

Lobradimil and Carboplatin in Treating Children With Brain Tumors

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Optic Nerve Glioma

NCT00001502 2008-03-04

A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
CNS

Brain Neoplasms, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡